Dalbavancin

Chemical formula: C₈₈H₁₀₀Cl₂N₁₀O₂₈ Molecular mass: 1,814.609 g/mol PubChem compound: 23724878

Therapeutic indications

Dalbavancin is indicated for:

Acute bacterial skin and skin structure infections (ABSSSI)

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Dalbavancin is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and paediatric patients aged 3 months and older.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1,500 mg once or 1,000 mg followed one week later by 500 mg

For patients from 6 to less than 18 years old 18 mg/kg once and for patients from 3 months to less than 6 years old 22.5 mg/kg once

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

Dalbavancin

Therapeutic indications

Acute bacterial skin and skin structure infections (ABSSSI)

1,500 mg once or 1,000 mg followed one week later by 500 mg

For patients from 6 to less than 18 years old 18 mg/kg once and for patients from 3 months to less than 6 years old 22.5 mg/kg once

Get recommendations

Related medicines